πππππ/ππππ: ππ₯π’π§π’πππ₯ ππ§π πππ¨π§π¨π¦π’π π
π’π§ππ’π§π π¬ ππ«π¨π¦ 40-π²πππ« π
π¨π₯π₯π¨π°-ππ© ππππ
On Tuesday December 10th, Quantify’s Emilie Toresson Grip is one of three speakers at ISPOR’s webinar on MASLD/ MASH following their BRIDGE-MASH study.
Moderated by Riku Ota, Global Payer Evidence Lead at Novo Nordisk, speakers Hannes HagstrΓΆm, Ying Shang and Emilie Toresson Grip will explore the findings of the BRIDGE-MASH study, assessing clinical and economic outcomes in a cohort of patients with an unprecedented follow-up period of more than 40 years.
Follow this link to sign up for the webinar
